|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimberg G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 2 | Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-rag loading doses of clopidogrel: results of the ISAR-CHOICE (Intraeoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect ) trim 显示文摘 | VON BECKCRATH N TAUBERT D POGATSA-MURRAY G | 2005 | Circulation2005，112，19： | 1 |
| 3 | Absorption,metabolization,and antiplatelet effects of 300-,600-,and 900-mgloading doses of clopidogrel:results of the ISAR-CHOICE(Intra-coronary Stenting and Antithrombotic Regimen:Choose Between 3High Oral Doses for Immediate Clopidogrel Effect)Trial显示文摘 | von Beckerath N Taubert D Pogatsa-Murray G | 2005 | Circu-lation2005，112，19： | 1 |
| 4 | Impact of P-glycopmtein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimberg G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 5 | Absorption,metabolization,and antiplatelet effects of 300-,600-,and 900-mg loading doses of clopidogrel:results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen:Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) trial显示文摘 | von Beckerath N Taubert D Pogatsa-Murray G | 2005 | Circulation2005，112，19： | 1 |
| 6 | Impact of P-glycoprotein on clopidogrel absorption 显示文摘 | Taubert D Von Beckerath N Grimberg G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 7 | Impact of P-glycoprotein on clopidogrel absorption 显示文摘 | Taubert D Von Beckerath N Grimberg G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 8 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimberg G | 2006 | Clin Phar-macol Ther2006，80，5： | 1 |
| 9 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimberg G | | 0，，05： | 1 |
| 10 | Absorption, metabolization, and antiplatelet effects of 300-, 600% and 900-mg loading doses of clopidogrel : Results of the ISAR-CHOICE ( intra- coronary stenting and antithrombotic regimen : Choose between 3 high oral doses for immediate clopidogrel effect) trial 显示文摘 | von Beckerath N Taubert D Pogatsa-Murray G | 2005 | Circulation2005，112，19： | 1 |
| 11 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | TAUBERT D von BECKERATH N GRIMBERG G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 12 | Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intraeoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial 显示文摘 | Von Beekerath N Taubert D Pogatsa-Murray G | 2005 | Circulation2005，112，19： | 1 |
| 13 | 冠心病和其他动脉粥样硬化性血管疾病二级预防指南:2006年版(摘要)显示文摘美国心脏学会(American College of Cardiology,ACC)与美国心脏病协会(American Heart Association.AHA)关于二级预防的共识声明自2001年更新以来,许多临床试验提供了重要证据.进一步支持和拓展了对冠心病和其他动脉粥样硬化性血管疾病(包括外周动脉疾病、动脉粥样硬化性主动脉疾病和颈动脉疾病)进行积极控制危险因素治疗的重要性。证据不断涌现,证实对这些患者进行积极而全面的危险因素干预治疗能够改善生存率,减少事件复发以及对介入治疗的需要.并提高生活质量。 | SMITH S C ALLEN J BLAIR S N BONOW R O BRASS L M FONAROW G C GRUNDY S M HIRATZKA L JONES D KRUMHOLZ H M MOSCA L PASTERNAK R C PEARSON T PFEFFER M A TAUBERT K A | 2008 | 岭南心血管病杂志2008，14，2： | 1 |
| 14 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimberg G | 2006 | Clin Pharmacol Ther2006，80，5： | 1 |
| 15 | Absorption, metabolization,and antiplatelet effects of 300-,600-,and 900-mg loading doses of clopidogrel-Results of the ISAR-CHOICE (intracoronary stenting and antithrombotic regimen:Choose between3 high oral doses for immediate clopidogrel effect)Trial显示文摘 | Von Beckerath N Taubert D Pogatsa-Murray G | 2005 | Circulation2005，112，19： | 1 |
| 16 | Impact of P-glyeoprotein on clopidogrel absorption 显示文摘 | Taubert D von Beckerath N G rimb ery G | 2006 | Clin Pharmacol2006，80，： | 1 |
| 17 | Absorption, metabolization, and antiplatelet effects of 300-, 600-,and 900-rag loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen : Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) trial 显示文摘 | yon Beckerath N Taubert D Pogatsa-Murray G | 2005 | Cirulation2005，112，19： | 1 |
| 18 | Impact of P-glycoprotein on clopidogrel absorption显示文摘 | Taubert D von Beckerath N Grimbery G | 2006 | Clin Pharmacol2006，80，： | 1 |
| 19 | Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial显示文摘 | VON BECKERATH N TAUBERT D POGATSA-MURRAY G | 2005 | Circulation2005，112，19： | 1 |
| 20 | Absorp tion, Metabolization, and Antiplatelet Effects of 300 -, 600 -, and 900- mg Loading Doses of Clopidogrel Results of the ISAR - CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial 显示文摘 | Von Beckerath N Taubert D Pogatsa - Murray G | 2005 | Circulation2005，112，29： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员